Clinical Trial Update: Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effects of saxagliptin and dapagliflozin on endothelial progenitor cells in patients with type 2 diabetes mellitus; study termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Saxagliptin (saxagliptin)

Snippet

Sponsor: Sabyasachi Sen | Conditions: Diabetes Mellitus, Type 2, Cardiovascular Diseases | Phase 4 | Status: TERMINATED | Results posted: 2023-06-05